Status:
COMPLETED
High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation
Lead Sponsor:
AHS Cancer Control Alberta
Collaborating Sponsors:
Cross Cancer Institute
Conditions:
Prostatic Neoplasm
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to establish the correct scanning parameters for obtaining good quality 3 Tesla (3T) magnetic resonance spectroscopy images (MRSI) of the prostate gland before and after b...
Eligibility Criteria
Inclusion
- Suitable candidate for prostate brachytherapy to treat prostate cancer
- Patient signs a study consent form
Exclusion
- Have received other radiotherapy for prostate cancer or hormone treatments
- Has contraindication to MRSI scanning
- Does not sign study consent form
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00126854
Start Date
October 1 2005
End Date
April 1 2011
Last Update
February 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2